Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors

Next-generation sequencing (NGS) of tumor samples and circulating tumor DNA has revolutionized diagnostic and therapeutic strategies in lung cancer. The identification of the epidermal growth factor receptor (EGFR) oncogenic driver has translated into successful therapy of advanced lung cancer using...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Justin A., Riess, Jonathan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Mechanisms of Resistance to EGFR-targeted Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330402/
https://www.ncbi.nlm.nih.gov/pubmed/32642199
http://dx.doi.org/10.21037/jtd.2019.08.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330402/
https://www.ncbi.nlm.nih.gov/pubmed/32642199
http://dx.doi.org/10.21037/jtd.2019.08.32

Ejemplares similares